Exact Mass: 369.1066390000001

A dibenzazecine alkaloid that is protopine bearing a hydroxy substituent at the 6-position.

Corpaine

Corysolidine, (+)

C12H20ClN3O6S (369.07612900000004)

S-(2-Chloroethyl)glutathione

ARQ-197

Tivantinib (ARQ 197)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

lansoprazole

2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole

A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BC - Proton pump inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29723 - Proton Pump Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D004791 - Enzyme Inhibitors > D054328 - Proton Pump Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; EAWAG_UCHEM_ID 3137 Lansoprazole (AG 1749) is an orally active proton pump inhibitor which prevents the stomach from producing acid. Lansoprazole (AG 1749) is a potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor (exosome inhibitor)[1][2].

Lansoprazole

2-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methanesulfinyl}-1H-1,3-benzodiazole

Lansoprazole is a proton pump inhibitor similar to omeprazole which prevents the stomach from producing acid. Lansoprazoles plasma elimination half-life is not proportional to the duration of the drugs effects (i.e. gastric acid suppression). The plasma elimination half-life is 1.5 hours or less, and the effects of the drug last for over 24 hours after it has been given for 5 days or more. [HMDB] Lansoprazole is a proton pump inhibitor similar to omeprazole which prevents the stomach from producing acid. Lansoprazoles plasma elimination half-life is not proportional to the duration of the drugs effects (i.e. gastric acid suppression). The plasma elimination half-life is 1.5 hours or less, and the effects of the drug last for over 24 hours after it has been given for 5 days or more. A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BC - Proton pump inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29723 - Proton Pump Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D004791 - Enzyme Inhibitors > D054328 - Proton Pump Inhibitors Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Lansoprazole (AG 1749) is an orally active proton pump inhibitor which prevents the stomach from producing acid. Lansoprazole (AG 1749) is a potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor (exosome inhibitor)[1][2].

Ochratoxin B

2-{[hydroxy(8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1H-2-benzopyran-7-yl)methylidene]amino}-3-phenylpropanoic acid

Ochratoxin B is a metabolite of Aspergillus ochraceu

Niazicinin

(2S,3R,4S,5R,6S)-4,5-dihydroxy-6-(4-{[(methoxycarbonyl)amino]methyl}phenoxy)-2-methyloxan-3-yl acetate

Niazicinin is a glucosinolate and a naturally occurring carbamate. It has been isolated from the leaves of Moringa oleifera (horseradish tree). It is found in fats and oils, herbs and spices, and green vegetables. The trans rotamer is named niazicinin A.

Isorheagenine

13-methyl-5,7,19,21,25-pentaoxa-13-azahexacyclo[12.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁸,²²]pentacosa-2(10),3,8,15(23),16,18(22)-hexaen-24-ol

C21H20FNO4 (369.13762920000005)

Rhoeagenine is an alkaloid from Papaver rhoeas (corn poppy

N-Deisopropyl-fluvastatin

(3S,5R,6E)-7-[3-(4-fluorophenyl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

N-Deisopropyl-fluvastatin is only found in individuals that have used or taken Fluvastatin. N-Deisopropyl-fluvastatin is a metabolite of Fluvastatin. N-deisopropyl-fluvastatin belongs to the family of Indoles. These are compounds containing an indole moiety, which consists of pyrrole ring fused to benzene to form 2,3-benzopyrrole.

Tripamide

N-[(1R,2S,6R)-4-Azatricyclo[5.2.1.0²,⁶]decan-4-yl]-4-chloro-3-sulphamoylbenzene-1-carboximidic acid

C16H20ClN3O3S (369.09138400000006)

Tripamide belongs to the family of Aromatic Monoterpenes. These are monoterpenes containing at least one aromatic ring. D045283 - Natriuretic Agents > D004232 - Diuretics > D049994 - Sodium Potassium Chloride Symporter Inhibitors D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D049990 - Membrane Transport Modulators

6-Hydroxy-R-acenocoumarol

4,6-dihydroxy-3-[(1S)-1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one

6-Hydroxy-R-acenocoumarol is a metabolite of acenocoumarol. Acenocoumarol is an anticoagulant that functions as a vitamin K antagonist. It is a derivative of coumarin and is marketed under the brand names Sintrom and Sinthrome. (Wikipedia)

7-Hydroxy-R-acenocoumarol

4,7-dihydroxy-3-[(1S)-1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one

7-Hydroxy-R-acenocoumarol is a metabolite of acenocoumarol. Acenocoumarol is an anticoagulant that functions as a vitamin K antagonist. It is a derivative of coumarin and is marketed under the brand names Sintrom and Sinthrome. (Wikipedia)

8-Hydroxy-R-acenocoumarol

4,8-dihydroxy-3-[(1S)-1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one

8-Hydroxy-R-acenocoumarol is a metabolite of acenocoumarol. Acenocoumarol is an anticoagulant that functions as a vitamin K antagonist. It is a derivative of coumarin and is marketed under the brand names Sintrom and Sinthrome. (Wikipedia)

2-Chloro-N6-cyclopentyladenosine

2-[2-chloro-6-(cyclopentylamino)-9H-purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol

C18H18F3NO4 (369.11878640000003)

Etofenamate

2-(2-Hydroxyethoxy)-ethyl-N-(alpha,alpha,alpha-trifluoro- m-tolyl)anthranilate

M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

Imrecoxib

4-(4-Methanesulphonylphenyl)-3-(4-methylphenyl)-1-propyl-2,5-dihydro-1H-pyrrol-2-one

C21H23NO3S (369.1398568000001)

2-[5-Methoxy-2-methyl-1-[(4-methylsulfanylphenyl)methyl]indol-3-yl]propanoic acid

2-(5-methoxy-2-methyl-1-{[4-(methylsulfanyl)phenyl]methyl}-1H-indol-3-yl)propanoic acid

C21H23NO3S (369.1398568000001)

D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids

Chloro-{methyl-[1-(2-methyl-5,6-dihydro-[1,4]oxathiin-3-yl)-methanoyl]-amino}-benzoic acid, isopropyl ester

C17H20ClNO4S (369.0801510000001)

(2S)-2-Amino-3-[(2S,3R)-2-amino-3-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]oxybutanoyl]oxypropanoic acid

Taspine

5-[2-(dimethylamino)ethyl]-7,14-dimethoxy-2,9-dioxatetracyclo[6.6.2.0⁴,¹⁶.0¹¹,¹⁵]hexadeca-1(15),4(16),5,7,11,13-hexaene-3,10-dione

6-methylthiohexyldesulfoglucosinolate

2-{[1-(hydroxyimino)-7-(methylsulphanyl)heptyl]sulphanyl}-6-(hydroxymethyl)oxane-3,4,5-triol

6-methylthiohexyldesulfoglucosinolate is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). 6-methylthiohexyldesulfoglucosinolate can be found in a number of food items such as quinoa, chinese mustard, sweet basil, and green bean, which makes 6-methylthiohexyldesulfoglucosinolate a potential biomarker for the consumption of these food products.

Papaverrubin A

N-Demethylisorheadine

Cassythic acid

(+)-Cassythic acid

5,6,7,7a-Tetrahydro-10-hydroxy-11-methoxy-8H-benzo[g]-1,3-benzodioxolo[6,5,4-de]quinoline-7-carboxylic acid methyl ester

(-)-O7-demethyl-adlumine|(R)-6-((R)-7-hydroxy-6-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-1-yl)-6H-furo[3,4:3,4]benzo[1,2-d][1,3]dioxol-8-one|severcine|Severtzin|severtzine

(+/-)-noradlumine|adlumine

Ara-C triacetate

Taxilamine

Dichotomide XI

C17H23NO6S (369.12460180000005)

A natural product found in Stellaria dichotoma var. lanceolata.

gamma-glutamylcystine

C11H19N3O7S2 (369.0664384)

Porritoxin sulfonic acid

Polyberbine

C18H24ClNO5 (369.13429240000005)

C18H24ClNO5

10-Hydroxychelidonine

C16H26Cl3NO2 (369.10290260000005)

axinyssimide B|axinyssimide C

cornigerine

Drahebephin A

((4,5-dichloro-1H-pyrrol-2-yl)-[2,4-dihydroxy-3-((S)-4-methylhexyl)phenyl]methanone)

C18H21Cl2NO3 (369.0898416)

(3R)-3-(5,8-dihydroxy-6-methoxy-2-methyl-4-oxo-4H-naphtho[2,3-b]pyran-10-yl)pyrrolidine-2,5-dione|(R)-10-(3-succinimidyl)-TMC-256A1

Drahebephin B

C20H19NO6

1,8-dihydroxy-6-(hydroxymethyl)-3-methoxy-2-(pyrrolidinium-2-yl) anthraquinone

aurodrosopterin

C15H15N9O3 (369.12978)

N-Formylduguevanine

Coryximine

corphthaline

SCHEMBL21149386

Paraensine

dioxindole-3-acetyl-3-O-beta-glucose

Tyr Thr Ser

Gly Met Tyr

ACMC-20mv1w

Ser Thr Tyr

Met Gly Tyr

Threonyltyrosylserine

Tyr Met Gly

Met Tyr Gly

Tenovin-1

N-[[[4-(acetylamino)phenyl]amino]thioxomethyl-4-(1,1-dimethylethyl)]-benzamide

Tenovin-1, a p53 activator, protects p53 from MDM2-mediated degradation. Tenovin-1 acts through inhibition of the protein-deacetylating activities of SirT1 and SirT2. Tenovin-1 is also a dihydroorotate dehydrogenase (DHODH) inhibitor[1][2].

Gly Tyr Met

Phe Cys Thr

Tyr Ser Thr

Thr Phe Cys

6-(methylsulfanyl)hexyl-desulfoglucosinolate

7-hydroxy-2-oxindole-3-acetate glucoside

Lycoramine HBr

(1R,12S,14S)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9-trien-14-ol;hydrobromide

C17H18F3N3O3 (369.13001940000004)

fleroxacin

Fleroxacin (Quinodis)

Fontanesine B

4-[2-[[2,3-dihydroxy-2-(1-hydroxyethyl)butanoyl]oxymethyl]anilino]-4-oxobutanoic acid

NCGC00347508-02!4-[2-[[2,3-dihydroxy-2-(1-hydroxyethyl)butanoyl]oxymethyl]anilino]-4-oxobutanoic acid

4-[2-[[(3S)-2,3-dihydroxy-2-[(1S)-1-hydroxyethyl]butanoyl]oxymethyl]anilino]-4-oxobutanoic acid

NCGC00347498-02!4-[2-[[(3S)-2,3-dihydroxy-2-[(1S)-1-hydroxyethyl]butanoyl]oxymethyl]anilino]-4-oxobutanoic acid

NCGC00180546-03

NCGC00180546-03!

2-Chloro-N6-cyclopentyladenosine

2-Chloro-N(6)-cyclopentyladenosine

ccpa

2-Chloro-N6-cyclopentyladenosine

C19H14N5F3 (369.12012400000003)

CCPA (2-Chloro-N6-cyclopentyladenosine) is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

MMV032967

OCHRATOXIN B

2-[(8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1H-2-benzopyran-7-yl)formamido]-3-phenylpropanoic acid

A phenylalanine derivative resulting from the formal condensation of the amino group of L-phenylalanine with the carboxy group of (3R)-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1H-2-benzopyran-7-carboxylic acid. Ochratoxin B differs from the more naturally abundant ochratoxin A in the absence of the dihydroisocoumarin chlorine atom. It has cytotoxic effects on kidney and liver cells in vitro but only minor effects in vivo, due to its rapid metabolism and excretion. It inhibits cell proliferation of human liver HepG2 cells at doses as low as 1 mug/ ml but lacks the genotoxic activity of ochratoxin A, even at higher concentrations. D009676 - Noxae > D011042 - Poisons > D009793 - Ochratoxins D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins CONFIDENCE Penicillium verrucosum

4-[2-[[(3S)-2,3-dihydroxy-2-[(1S)-1-hydroxyethyl]butanoyl]oxymethyl]anilino]-4-oxobutanoic acid [IIN-based: Match]

NCGC00347498-02!4-[2-[[(3S)-2,3-dihydroxy-2-[(1S)-1-hydroxyethyl]butanoyl]oxymethyl]anilino]-4-oxobutanoic acid [IIN-based: Match]

4-[2-[[(3S)-2,3-dihydroxy-2-[(1S)-1-hydroxyethyl]butanoyl]oxymethyl]anilino]-4-oxobutanoic acid [IIN-based on: CCMSLIB00000848675]

NCGC00347498-02!4-[2-[[(3S)-2,3-dihydroxy-2-[(1S)-1-hydroxyethyl]butanoyl]oxymethyl]anilino]-4-oxobutanoic acid [IIN-based on: CCMSLIB00000848675]

Thr Tyr Ser

Phe Cys Thr

C15H13F2N3O4S (369.05948020000005)

4-Pyridinol, 2-[[[5-(difluoromethoxy)-1H-benzimidazol-2-yl]sulfinyl]methyl]-3-methoxy-

Cys Thr Phe

Ser Tyr Thr

Met Gly Tyr

Tyr Met Gly

Met Tyr Gly

Diethylpropion(metabolite X-glucuronide)

Cys Phe Thr

Thr Phe Cys

7-Desmethylprazosin

6-Desmethylprazosin

Phe Thr Cys

Thr Ser Tyr

Gly Tyr Met

Thr Cys Phe

Tyr Gly Met

Gly Met Tyr

C21H20FNO4 (369.13762920000005)

(3R,5S,6E)-rel-7-[3-(4-fluorophenyl)-1H-indol-2-yl]-3,5-dihydroxy-6-Heptenoic acid

PC(3:0/3:0)

3,5,9-Trioxa-4-phosphadodecan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-(1-oxopropoxy)-, inner salt, 4-oxide, (R)-

Dipropionylphosphatidylcholine

3,5,9-Trioxa-4-phosphadodecan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-(1-oxopropoxy)-, inner salt, 4-oxide

2H-1-Benzopyran-2-one, 4,8-dihydroxy-3-[(1S)-1-(4-nitrophenyl)-3-oxobutyl]- (Acenocoumarol metaboli

2H-1-Benzopyran-2-one, 4,7-dihydroxy-3-[(1S)-1-(4-nitrophenyl)-3-oxobutyl]- (Acenocoumarol metabolit

Gly-Trp-OH

(S)-2-(3-hydroxy-4-nitrobenzamido)-3-(1H-indol-3-yl)propanoic acid

C18H15N3O6 (369.096081)

Lys-Asp-OH

(S)-2-(3-(4-aminobutoxy)-4-nitrobenzamido)pentanedioic acid

Thr-Lys-OH

Asp-Lys-OH

(S)-7-amino-2-(3-(carboxymethoxy)-4-nitrobenzamido)heptanoic acid

Thaspine

Homapin

3-[(2-hydroxy-2-phenylacetyl)oxy]-8,8-dimethyl-8-azabicyclo[3.2.1]octan-8-ium bromide

A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03B - Belladonna and derivatives, plain > A03BB - Belladonna alkaloids, semisynthetic, quaternary ammonium compounds Homatropine methylbromide (Homatropine methobromide) is muscarinic AChR antagonist, inhibits endothelial and smooth muscle muscarinic receptors of WKY-E and SHR-E with IC50 of 162.5 nM and 170.3 nM, respectively.

Isorheagenine

13-methyl-5,7,19,21,25-pentaoxa-13-azahexacyclo[12.11.0.0^{2,10}.0^{4,8}.0^{15,23}.0^{18,22}]pentacosa-2,4(8),9,15,17,22-hexaen-24-ol

Niazicinin A

4,5-dihydroxy-6-(4-{[(methoxycarbonyl)amino]methyl}phenoxy)-2-methyloxan-3-yl acetate

C16H20ClN3O3S (369.09138400000006)

Normonal

N-[(1R,2S,6R)-4-azatricyclo[5.2.1.0^{2,6}]decan-4-yl]-4-chloro-3-sulfamoylbenzene-1-carboximidic acid

D045283 - Natriuretic Agents > D004232 - Diuretics > D049994 - Sodium Potassium Chloride Symporter Inhibitors D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D049990 - Membrane Transport Modulators

3-C-[({2-[(3-Carboxypropanoyl)amino]benzyl}oxy)carbonyl]-1,5-dideoxypentitol

3-C-[({2-[(3-Carboxypropanoyl)amino]benzyl}oxy)carbonyl]-1,5-dideoxy-L-arabinitol

PC 6:0

1,2-dipropionyl-sn-glycero-3-phosphocholine

Fmoc-D-Glu-OH

C20H20FN3OS (369.13110420000004)

methyl 4-[2-[4-(5-methyl-2-benzoxazolyl)phenyl]vinyl]benzoate

C24H19NO3 (369.1364864000001)

Acetamide, 2-[[2-(4-fluorophenyl)-7-methyl-4-quinazolinyl]thio]-N-(1-methylethyl)- (9CI)

[4-(4-chloro-phenyl)-piperazin-1-yl]-(1h-indol-2-yl)-acetic acid

C20H20ClN3O2 (369.12439700000004)

(r,r)-7-amino-3-(1-methylpyrrolidinio)methyl-3-cephem-4-carboxylate hcl

C13H21Cl2N3O3S (369.0680616000001)

10-Methyl-9-phenylacridinium perchlorate

C20H16ClNO4 (369.07678060000006)

2-{[1-(TERT-BUTOXYCARBONYL)PIPERIDIN-4-YL]SULFONYL}BENZOICACID

C17H23NO6S (369.12460180000005)

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-(15N)glutamic acid

(2-Pyridinyl)tributylstannane

C17H31NSn (369.1478356)

Fmoc-Asp-Ome

2,6-Bis[(4S)-phenyl-2-oxazolin-2-yl]pyridine

2,5-Pyrrolidinedione, 3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-, (3S,4S)

alpha,alpha-bis[4-(dimethylamino)phenyl]-4-(ethylamino)naphthalene-1-methanol

C16H20BrNO4 (369.0575620000001)

4-(4-bromophenyl)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-3-carboxylic acid

2,4-D-trolamine

C14H21Cl2NO6 (369.07458660000003)

4-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-[4-(trifluoromethyl)phenyl]-1,3-thiazole

C17H19BF3NO2S (369.11815800000005)

BOC-(R)-3-AMINO-4-PENTAFLUOROPHENYLBUTANOIC ACID

C15H16F5NO4 (369.0999436)

Gallium,tris(2,4-pentanedionato-kO,kO)-, (OC-6-11)- (9CI)

C15H24GaO6 (369.0828614)

Boc-trans-DL-b-Pro-4-(3-bromophenyl)-OH

C16H20BrNO4 (369.0575620000001)

sodium 4-[(4-chlorobenzoyl)(4-methoxyphenyl)amino]butyrate

C18H17ClNNaO4 (369.0743752000001)

Disperse Yellow Se-Fl

C18H15N3O4S (369.07832300000007)

RU58841

C17H18F3N3O3 (369.13001940000004)

3-METHYLCYTIDINE METHOSULFATE

C11H19N3O9S (369.0841964)

diethyl 1-tosylpyrrolidine-2,5-dicarboxylate

C17H23NO6S (369.12460180000005)

3-(Tributylstannyl)pyridine

C17H31NSn (369.1478356)

Lansoprazole Sulfide N-Oxide

4-(TERT-BUTOXYCARBONYLAMINO)-1-[(6-BROMOPYRIDIN-2-YL)METHYL]PIPERIDINE

C16H24BrN3O2 (369.1051784)

Fmoc-Ser(Ac)-OH

Fmoc-Glu-OH

8,14-Dihydro-14-methyl-11-(trifluoromethyl)-indolo[2,3:3,4]pyrido[2,1-b]quinazolin-5(7H)-one

C20H14F3N3O (369.108891)

BOC-(S)-3-AMINO-4-PENTAFLUOROPHENYLBUTANOIC ACID

C15H16F5NO4 (369.0999436)

(+)-Egenine

Fmoc-Asp(OMe)-OH

C20H20BrNO (369.07281700000004)

(5-Bromo-1-pentyl-1H-pyrrol-3-yl)(naphthalen-1-yl)methanone

4-(2-bromophenyl)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-3-carboxylic acid

C16H20BrNO4 (369.0575620000001)

5-azido-1,3-dimethyl-6-nitro-8-phenylpyrido[2,3-d]pyrimidine-2,4,7-trione

C15H11N7O5 (369.0821636)

Dextromethorphan Hydrobromide Monohydrate

C18H28BrNO2 (369.13032880000003)

D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents

ETHYL 5-HYDROXY-8-(2-METHOXYETHYL)-7-OXO-2-PHENYL-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDINE-6-CARBOXYLATE

C17H19MgN3O3S (369.09975640000005)

Omeprazole magnesium

Disperse Yellow 56

C21H15N5O2 (369.122569)

ethyl 4,5-bis(4-methoxyphenyl)-1,3-thiazole-2-carboxylate

C20H19NO4S (369.1034734000001)

N-[6-(1H-indazol-5-yl)naphthalen-2-yl]thiophene-2-carboxamide

C22H15N3OS (369.09357800000004)

N-[6-(1H-indazol-4-yl)naphthalen-2-yl]thiophene-3-carboxamide

C22H15N3OS (369.09357800000004)

N-[6-(1H-indazol-5-yl)naphthalen-2-yl]thiophene-3-carboxamide

C22H15N3OS (369.09357800000004)

8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid

C19H13ClFN3O2 (369.068028)

Fmoc-D-Asp-OMe

Azaphen

C16H21Cl2N5O (369.1123076)

Thiazolidine, 2-(4-methylphenyl)-3-(1-naphthalenylsulfonyl)- (9CI)

C20H19NO2S2 (369.0857154)

Thiazolidine, 2-(4-methylphenyl)-3-(2-naphthalenylsulfonyl)- (9CI)

C20H19NO2S2 (369.0857154)

(S)-Lansoprazole

Hyoscyamine Hydrobromide

C8H28Cl5N5 (369.07872380000003)

ADX-47273

C20H17F2N3O2 (369.1288766)

ADX-47273 is a potent, selective and brain-penetrant mGluR5 positive allosteric modulator (PAM), with an EC50 of 0.17 μM for potentiation of glutamate (50 nM) response. ADX-47273 has antipsychotic and procognitive activities[1][2].

Tetraethylenepentamine Pentahydrochloride

4-(6-acetyl-1,3,7-trimethyl-2,4-dioxo-5,8-dihydropyrido[2,3-d]pyrimidin-5-yl)benzoic acid

C17H20ClNO4S (369.0801510000001)

3,4-Dibenzyloxyphenethylamine hydrochloride

C22H24ClNO2 (369.1495474)

3-(Methylsulfonyl)-L-phenylalanine phenylmethyl ester hydrochloride

1,1,2,3-tetramethyl-1H-benzo[e]indolium hexafluorophosphate(V)

C16H18N.F6P (369.108099)

2-(2,4-dihydroxyphenyl)-4,6-bis(4-methylphenyl)-1,3,5-triazine

C20H20ClN3O2 (369.12439700000004)

C.I. Basic Yellow 40

1(2H)-PyriMidineacetic acid, 4-[bis[(1,1-diMethylethoxy)carbonyl]aMino]-2-oxo-

2,6-Bis[(4R)-4-phenyl-2-oxazolinyl]pyridine

4-[3-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-BENZENESULFONYL]-THIOMORPHOLINE

C16H24BNO4S2 (369.1239734)

tert-butyl 4-[(4-bromophenyl)methoxy]piperidine-1-carboxylate

4-(Tributylstannyl)pyridine

C17H31NSn (369.1478356)

(+)-Corlumidine

Dexlansoprazole

C23H16ClN3 (369.10326860000004)

A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BC - Proton pump inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29723 - Proton Pump Inhibitor D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents D004791 - Enzyme Inhibitors > D054328 - Proton Pump Inhibitors (R)-Lansoprazole is the R enantiomer of Lansoprazole, Lansoprazole (AG 1749) is an orally active proton pump inhibitor which prevents the stomach from producing acid. Lansoprazole (AG 1749) is a potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor (exosome inhibitor)[1][2].

1-(anthracen-9-ylmethyl)-4-(2-chlorophenyl)triazole

Bromo-WR99210

C14H20BrN5O2 (369.080028)

Deudextromethorphan hydrobromide

C18H28BrNO2 (369.13032880000003)

C78272 - Agent Affecting Nervous System

2-[(8-Hydroxy-3-methyl-1-oxoisochroman-7-carbonyl)amino]-3-phenylpropionic acid

Chrysobactin

C16H17F2N3O3S (369.09586360000003)

A catechol-type siderophore with a structure of D-lysyl-L-serine substituted on N(2) of the lysyl residue by a 2,3-dihydroxybenzoyl group. It is produced by the Gram-negative bacillus Dickeya dadantii (previously known as Erwinia chrysanthem). Only the catecholate hydroxyl groups participate in metal coordination, so chrysobactin cannot provide full 1:1 coordination of Fe(III); at neutral pH and concentrations of about 0.1 mM, ferric chrysobactin exists as a mixture of bis and tris complexes.

Cephalexin sodium

C16H16N3NaO4S (369.0759176)

Mmp-9-IN-1

4-[5-(2-Phenylethyl)-2-sulfanylidene-1,3,5-triazinan-1-yl]benzoic acid ethyl ester

(2,5-dioxopyrrolidin-3-yl) N-[(4-methoxyphenyl)methyl]-N-phenylcarbamimidothioate

Tyr-Met-Gly

6-[[(4,6-dimethyl-2-pyrimidinyl)thio]methyl]-N2-(4-methoxyphenyl)-1,3,5-triazine-2,4-diamine

C17H19N7OS (369.1371724)

2-[(3,5-Dimethyl-1,2-oxazol-4-yl)methylsulfanyl]-4-ethyl-7,7-dimethyl-5-oxo-6,8-dihydroquinoline-3-carbonitrile

C21H20ClNO3 (369.1131640000001)

JWH 203 N-pentanoic acid metabolite

L-Threonyl-L-seryl-L-tyrosine

C20H20ClN3S (369.1066390000001)

N-(4-{2-[(3-Chlorobenzyl)amino]ethyl}phenyl)thiophene-2-carboximidamide

N-(4-(5-((1H-Benzimidazol-2-ylamino)methyl)-2-thienyl)-1,3-thiazol-2-YL)guanidine

C16H15N7S2 (369.083031)

2-{5-[Amino(iminio)methyl]-6-chloro-1H-indol-2-YL}-6-(cyclopentyloxy)benzenolate

C20H20ClN3O2 (369.12439700000004)

Homatropine Methylbromide

C18H18F3NO4 (369.11878640000003)

A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03B - Belladonna and derivatives, plain > A03BB - Belladonna alkaloids, semisynthetic, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent Homatropine methylbromide (Homatropine methobromide) is muscarinic AChR antagonist, inhibits endothelial and smooth muscle muscarinic receptors of WKY-E and SHR-E with IC50 of 162.5 nM and 170.3 nM, respectively.

Etofenamate

N-(pyridin-4-ylmethyl)-2-[3-(trifluoromethyl)phenyl]-1H-imidazo[4,5-c]pyridin-4-amine

C19H14F3N5 (369.12012400000003)

2-[[6-Amino-2-[(2,3-dihydroxybenzoyl)amino]hexanoyl]amino]-3-hydroxypropanoic acid

(2E)-3-[(2R,3R)-3-formyl-2-(4-hydroxy-3-methoxyphenyl)-7-methoxy-2,3-dihydro-1-benzofuran-5-yl]prop-2-enoate

(2E)-3-[(2S,3S)-3-formyl-2-(4-hydroxy-3-methoxyphenyl)-7-methoxy-2,3-dihydro-1-benzofuran-5-yl]prop-2-enoate

7-(beta-D-glucosyloxy)-2-oxindole-3-acetic acid

L-arginyl-4-hydroxy-5-phosphonopentanoate

C11H24N5O7P (369.1413284)

6-(Methylthio)hexyl-desulfoglucosinolate

Dehydrodiconiferyl acid ketone

Iso-dehydrocycloxanthohumol hydrate

C21H21O6- (369.1338066)

2-[2-oxo-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1H-indol-3-yl]acetic acid

2-[[6-Azaniumyl-2-[(2,3-dihydroxybenzoyl)amino]hexanoyl]amino]-3-hydroxypropanoate

2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]-4-hydroxy-5-phosphonopentanoic acid

C11H24N5O7P (369.1413284)

2-[2-oxo-3-[(2S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1H-indol-3-yl]acetic acid

(2S)-2-Amino-3-[(2S,3R)-2-amino-3-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]oxybutanoyl]oxypropanoic acid

6-methylthiohexyldesulfoglucosinolate

C16H20ClN3O3S (369.09138400000006)

Tripamide

D045283 - Natriuretic Agents > D004232 - Diuretics > D049994 - Sodium Potassium Chloride Symporter Inhibitors D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic D049990 - Membrane Transport Modulators

Norsolorinate(1-)

An organic anion obtained by selective deprotonation of the 2-hydroxy group of norsolorinic acid.

N-methyl-3-[5-(3-phenylpropyl)-1,3,4-oxadiazol-2-yl]-N-(3-thiophenylmethyl)propanamide

6-(1,3-benzodioxol-5-yl)-N-[(3-methylphenyl)methyl]-4-quinazolinamine

C14H19N5O3S2 (369.09292639999995)

N-[(3-cyano-6-methyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)carbamothioyl]-2-methylbenzamide

C19H19N3OS2 (369.0969484)

2-[(5-butyl-1H-1,2,4-triazol-3-yl)thio]-N-(4-sulfamoylphenyl)acetamide

N-(2,4-dimethylphenyl)sulfonyl-2-(1-naphthalenyloxy)acetamide

C20H19NO4S (369.1034734000001)

2-[[1-oxo-2-[[5-(3-pyridinyl)-1H-1,2,4-triazol-3-yl]thio]ethyl]amino]benzoic acid methyl ester

C17H15N5O3S (369.089556)

H-Thr-tyr-ser-OH

4-[(3-oxo-4H-1,4-benzoxazin-7-yl)sulfonyl]-1-piperazinecarboxylic acid ethyl ester

C15H19N3O6S (369.0994514)

9-Methoxy-6-[(4-methoxyphenyl)methyl]indolo[3,2-b]quinoxaline

2-(1H-benzimidazol-2-ylthio)-1-[2,5-dimethyl-1-(2-oxolanylmethyl)-3-pyrrolyl]ethanone

C18H15N3O4S (369.07832300000007)

(E)-3-[5-(4-Acetyl-phenyl)-furan-2-yl]-2-(5-methyl-4H-[1,2,4]triazol-3-ylsulfanyl)-acrylic acid

Isopropyl (3-oxo-1-{[(2-thienylcarbonyl)amino]carbonothioyl}-2-piperazinyl)acetate

C15H19N3O4S2 (369.0816934)

N4-(4-Fluorophenyl)-N5-(2-nitrophenyl)-1H-imidazole-4,5-dicarboxamide

C17H12FN5O4 (369.08732840000005)

N-(6-tert-butyl-3-cyano-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-5-cyclopropyl-1,2-oxazole-3-carboxamide

2-methoxy-N-[[2-(1-piperidinyl)anilino]-sulfanylidenemethyl]benzamide

N-[5-(dimethylsulfamoyl)-2-methylphenyl]-2-quinolinecarboxamide

N-[3-(dimethylsulfamoyl)-4-methylphenyl]-2-quinolinecarboxamide

2,4-dimethyl-N-[[4-(4-morpholinyl)anilino]-sulfanylidenemethyl]benzamide

C16H20FN3O4S (369.11584920000007)

5-(4-Fluorophenyl)sulfonyl-1-(2-methylpropyl)-4-nitro-2-propan-2-ylimidazole

2-[[[1-(2-Methoxy-5-methylphenyl)-5-tetrazolyl]thio]methyl]-1,3-benzothiazole

C17H15N5OS2 (369.071798)

5-[(2-Chlorophenyl)methylamino]-2-(3,4-dimethoxyphenyl)-4-oxazolecarbonitrile

C19H16ClN3O3 (369.08801360000007)

N-{[3-(4-chlorophenyl)-1H-pyrazol-4-yl]methylene}-4-nitrobenzohydrazide

C17H12ClN5O3 (369.06286320000004)

2-[2-(3-Cyano-4-methoxymethyl-6-methyl-2-oxo-2H-pyridin-1-yl)-acetylamino]-benzoic acid methyl ester

2-[[5-[(2-Methyl-8-quinolinyl)oxymethyl]-4-prop-2-enyl-1,2,4-triazol-3-yl]thio]acetamide

C18H19N5O2S (369.1259394)

3-(2-furyl)-N-({[4-(4-methylphenyl)-1,3-thiazol-2-yl]amino}carbonothioyl)acrylamide

C18H15N3O2S2 (369.060565)

5-[[2-(Diethylamino)-9-methyl-4-oxo-3-pyrido[1,2-a]pyrimidinyl]methylidene]-1,3-diazinane-2,4,6-trione

C22H13N2O4- (369.08752780000003)

didemethylasterriquinone D(1-)

N-(2-methoxy-5-methylphenyl)-2-[[1-(phenylmethyl)-5-tetrazolyl]thio]acetamide

C18H19N5O2S (369.1259394)

2-(benzotriazol-1-yl)-N-[(Z)-(3,4,5-trimethoxyphenyl)methylideneamino]acetamide

1-(7-methyl-5-oxo-[1,3,4]thiadiazolo[3,2-a]pyrimidin-2-yl)-N-(4-methylphenyl)-2-pyrrolidinecarboxamide

C18H19N5O2S (369.1259394)

(4Z)-4-[(3-methoxyphenyl)methylidene]-2-(3-methylphenyl)isoquinoline-1,3-dione

C24H19NO3 (369.1364864000001)

2-(3,4-dimethoxyphenyl)-N-[(E)-[(E)-3-(3-nitrophenyl)prop-2-enylidene]amino]acetamide

N-ethyl-3-(1H-indol-3-yl)-N-[2-oxo-2-(thiophen-2-ylmethylamino)ethyl]propanamide

4-[(Z)-N-anilino-C-(quinolin-2-ylmethyl)carbonimidoyl]benzene-1,3-diol

4-[2-[[(3S)-2,3-Dihydroxy-2-[(1S)-1-hydroxyethyl]butanoyl]oxymethyl]anilino]-4-oxobutanoic acid

Nedocromil(2-)

C19H15NO7-2 (369.084848)

5-(dimethylamino)-N-(4-nitrosobenzyl)naphthalene-1-sulfonamide

Ser-Thr-Tyr

Gly-Tyr-Met

Cys-Thr-Phe

Thr-Phe-Cys

6-(Methylthio)hexyldesulfoglucosinolate

An omega-(methylsulfany)alkyl desulfoglucosinolate in which the omega-(methylsulfanyl)alkyl group is specified as 6-(methylsulfanyl)hexyl.

8-{[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]thio}-9H-purin-6-amine

C17H19N7OS (369.1371724)

(5E)-5-[[1-(2-methoxy-5-methylphenyl)-2,5-dimethylpyrrol-3-yl]methylidene]-3-methyl-2-methylimino-1,3-thiazolidin-4-one

cyclopropyl-[(2R,3R)-2-(hydroxymethyl)-3-phenyl-1-(2-thiazolylmethyl)-1,6-diazaspiro[3.3]heptan-6-yl]methanone

cyclopropyl-[(2S,3S)-2-(hydroxymethyl)-3-phenyl-1-(2-thiazolylmethyl)-1,6-diazaspiro[3.3]heptan-6-yl]methanone

cyclopropyl-[(2S,3R)-2-(hydroxymethyl)-3-phenyl-1-(2-thiazolylmethyl)-1,6-diazaspiro[3.3]heptan-6-yl]methanone

Tyr-Thr-Ser

Phe-Cys-Thr

Phe-Thr-Cys

Ser-Tyr-Thr

Thr-Cys-Phe

Cys-Phe-Thr

Gly-Met-Tyr

Met-Gly-Tyr

Met-Tyr-Gly

Tyr-Gly-Met

Tyr-Ser-Thr

C22H15N3O3 (369.11133600000005)

Erdasporine A

A organic heterohexacyclic compound that is 12,13-dihydro-6H-indolo[2,3-a]pyrrolo[3,4-c]carbazole in which the hydrogens at positions 5 and 10 are substituted by a methoxycarbonyl and hydroxy groups, respectively. It is synthesized by a gene cluster found in environmental DNA and exhibits cytotoxic activity against human HCT116 cancer cells and Staphylococcus aureus.

Erdasporine C

C22H15N3O3 (369.11133600000005)

An organic heterohexacyclic compound that is 6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole in which the hydrogens at positions 5 and 7 are substituted by a methoxycarbonyl and oxo groups, respectively. It is synthesized by a gene cluster found in environmental DNA and exhibits cytotoxic activity against human HCT116 cancer cells and Staphylococcus aureus.

(E)-N-[2-[(2E)-2-[(2,4-dihydroxyphenyl)methylidene]hydrazinyl]-2-oxoethyl]-3-(4-methoxyphenyl)prop-2-enamide

(5Z)-1-Prop-2-enyl-5-[(1-propyl-3,4-dihydro-2H-quinolin-6-yl)methylidene]-2-sulfanylidene-1,3-diazinane-4,6-dione

Carbonic acid [4-[2-(ethoxycarbonylamino)ethyl]-2-ethoxycarbonyloxyphenyl] ethyl ester

2-Hydroxy-2,2-di(1-hydroxyethyl)acetic acid 2-(4-hydroxy-4-oxobutanoylamino)benzyl ester

2,3-Di(propanoyloxy)propyl 2-(trimethylazaniumyl)ethyl phosphate

Lnape 2:0/N-7:0

Lnape 3:0/N-6:0

Lnape 7:0/N-2:0

Lnape 6:0/N-3:0

Lnape 4:0/N-5:0

Lnape 5:0/N-4:0

C24H25Si2 (369.14947099999995)

8-Trimethylsilyl-1-(methyl(1-naphthyl)silyl)naphthalene

(3-Acetyloxy-2-butanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

[1-Acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] heptanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] hexanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-butanoyloxypropan-2-yl] pentanoate

C21H20FNO4 (369.13762920000005)

N-Deisopropyl-fluvastatin

6-Hydroxy-R-acenocoumarol

(S)-7-Hydroxyacecoumarol

8-Hydroxy-R-acenocoumarol

1,2-dipropionyl-sn-glycero-3-phosphocholine

(-)-DCA-CL(1-)

C20H17O7 (369.0974232)

A monocarboxylic acid anion that is the conjugate base of (-)-DCA-CL, obtained by deprotonation of the carboxy group; major species at pH 7.3.

(+)-DCA-CL(1-)

C20H17O7 (369.0974232)

A monocarboxylic acid anion that is the conjugate base of (+)-DCA-CL, obtained by deprotonation of the carboxy group; major species at pH 7.3.

7-hydroxy-2-oxindole-3-acetic acid beta-D-glucoside

C18H25NO.BrH.H2O (369.13032880000003)

A member of the class of oxindoles that is 7-hydroxy-2-oxindole-3-acetic acid in which the phenolic hydrogen has been replaced by a beta-D-glucosyl residue.

Dextromethorphan Hydrobromide

PC 3:0/3:0

C12H20NO10P (369.08247900000003)

LPE 7:3;O3

LPE 8:2;O2

C13H24NO9P (369.1188624)

LPE 9:1;O

C12H20NO10P (369.08247900000003)

LPS 6:2;O

Thr-Ser-Tyr

Thr-Tyr-Ser